Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 1 SUPPL., 2012, Pages

  Holscher, Hannah D ^a   Faust, Kristin L ^a   Czerkies, Laura A ^b   Litov, Richard ^c   Ziegler, Ekhard E ^d   Lessin, Herschel ^e   Hatch, Terry ^f   Sun, Shumei ^g   Tappenden, Kelly A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c Pedia Research   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e Childrens Medical Group   (United States)

^f Carle Clinic   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Nutrition; Pediatrics; Prebiotics

Indexed keywords

ACETIC ACID; BUTYRIC ACID; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; PREBIOTIC AGENT; PROPIONIC ACID; 4' GALACTOOLIGOSACCHARIDE; 4'-GALACTOOLIGOSACCHARIDE; IDOLAX; OLIGOSACCHARIDE; TRISACCHARIDE; VOLATILE FATTY ACID;

ARTICLE; ARTIFICIAL MILK; BACTEROIDES; BIFIDOBACTERIACEAE; BREAST FEEDING; BREAST MILK; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; FECES MICROFLORA; HUMAN; INFANT; LACTOBACILLUS; NUTRITIONAL TOLERANCE; PH; PREVOTELLA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WHEY; BIFIDOBACTERIUM; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FECES; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; METAGENOME; MICROBIOLOGY; PROSPECTIVE STUDY;

BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, VOLATILE; FECES; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN-ION CONCENTRATION; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT FORMULA; METAGENOME; OLIGOSACCHARIDES; PREBIOTICS; PROSPECTIVE STUDIES; TRISACCHARIDES;

EID: 84860571162     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111430087     Document Type: Article

References (50)

1. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG. Effects of infant formula containing a mixture of galacto-and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr. 2005;94:783-790.
2. Scholtens PA, Alliet P, Raes M, et al. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructooligosaccharides. J Nutr. 2008;138:1141-1147.
3. Gruber C, van Stuijvenberg M, Mosca F, et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol. 2010;126:791-797.
4. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91:814.
5. Arslanoglu S, Moro GE, Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr. 2007;137:2420-2424.
6. Bettelheim KA, Breadon A, Faiers MC, O'Farrell SM, Shooter RA. The origin of O serotypes of Escherichia coli in babies after normal delivery. J Hyg (Lond). 1974;72:67-70.
7. Brook I, Barrett CT, Brinkman CR III, Martin WJ, Finegold SM. Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: a prospective study. Pediatrics. 1979;63:451-455.
8. Lennox-King SM, O'Farrell SM, Bettelheim KA, Shooter RA. Colonization of caesarean section babies by Escherichia coli. Infection. 1976;4:134-138.
9. Lennox-King SM, O'Farrell SM, Bettelheim KA, Shooter RA. Escherichia coli isolated from babies delivered by caesarean section and their environment. Infection. 1976;4:139-145.
10. Heikkila MP, Saris PE. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol. 2003;95:471-478.
11. Martín R, Langa S, Reviriego C, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143:754-758.
12. Boehm G, Jelinek J, Stahl B, et al. Prebiotics in infant formulas. J Clin Gastroenterol. 2004;38:S76-S79.
13. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999;69:1052S-1057S.
14. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-1412.
15. Moro G, Minoli I, Mosca M, et al. Dosage-related bifidogenic effects of galacto-and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34:291-295.
16. Schmelzle H, Wirth S, Skopnik H, et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr. 2003;36:343-351.
17. Knol J, Boehm G, Lidestri M, et al. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr Suppl. 2005;94:31-33.
18. Knol J, Scholtens P, Kafka C, et al. Colon microflora in infants fed formula with galacto-and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40:36-42.
19. Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2005;71:2318-2324.
20. Costalos C, Kapiki A, Apostolou M, Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev. 2008;84:45-49.
21. Braegger C, Chmielewska A, Decsi T, et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr. 2011;52:238-250.
22. Waligora-Dupriet AJ, Campeotto F, Nicolis I, et al. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int J Food Microbiol. 2007;113:108-113.
23. Ziegler E, Vanderhoof JA, Petschow B, et al. Term infants fed formula supplemented with selected blends of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants. J Pediatr Gastroenterol Nutr. 2007;44:359-364.
24. Ben XM, Zhou XY, Zhao WH, et al. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin Med J (Engl). 2004;117:927-931.
25. Moro GE, Mosca F, Miniello V, et al. Effects of a new mixture of prebiotics on faecal flora and stools in term infants. Acta Paediatr Suppl. 2003;91:77-79.
26. Thurl S, Henker J, Taut H, Tovar K, Sawatzki G. Variations of neutral oligosaccharides and lactose in human milk during the feeding. Z Ernahrungswiss. 1993;32:262-269.
27. Smiricky-Tjardes MR, Flickinger EA, Grieshop CM, Bauer LL, Murphy MR, Fahey GC. In vitro fermentation characteristics of selected oligosaccharides by swine fecal microflora. J Anim Sci. 2003;81:2505.
28. Coppa GV, Pierani P, Zampini L, Bruni S, Carloni I, Gabrielli O. Characterization of Oligosaccharides in Milk and Feces of Breast-Fed Infants by High Performance Anion Exchange Chromatography. New York: Kluwer Academic/Plenum; 2001.
29. Chaturvedi P, Warren CD, Buescher CR, Pickering LK, Newburg DS. Survival of human milk oligosaccharides in the intestine of infants. Adv Exp Med Biol. 2001;501:315-323.
30. Matteuzzi D, Swennen E, Rossi M, Hartman T, Lebet V. Prebiotic effects of a wheat germ preparation in human healthy subjects. Food Microbiol. 2004;21:119-124.
31. Association of Official Analytical Chemists, ed. Official Methods of Analysis. Washington, DC: AOAC; 1984. No. 14.
32. Kramer CY. Extension of multiple range tests to group means with unequal numbers of replications. Biometrics. 1956;12:307-310.
33. Tukey JW. Unsolved problems of experimental statistics. J Am Stat Assoc. 1954;49:706-731.
34. Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol. 1993;75:373-380.
35. Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511-521.
36. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20:699-722.
37. Schroten H, Lethen A, Hanisch FG, et al. Inhibition of adhesion of S-fimbriated Escherichia coli to epithelial cells by meconium and feces of breast-fed and formula-fed newborns: mucins are the major inhibitory component. J Pediatr Gastroenterol Nutr. 1992;15: 150-158.
38. Schwertmann A, Schroten H, Hacker J, Kunz C. S-fimbriae from Escherichia coli bind to soluble glycoproteins from human milk. J Pediatr Gastroenterol Nutr. 1999;28:257-263.
39. Ahtonen P, Lehtonen OP, Kero P, Eerola E, Hartiala K. Clostridium perfringens in stool, intrapartum antibiotics and gastrointestinal signs in a neonatal intensive care unit. Acta Paediatr. 1994;83:389-390.
40. Petschow BW, Talbott RD. Growth promotion of Bifidobacterium species by whey and casein fractions from human and bovine milk. J Clin Microbiol. 1990;28:287-292.
41. Balmer SE, Scott PH, Wharton BA. Diet and faecal flora in the newborn: casein and whey proteins. Arch Dis Child. 1989;64:1678-1684.
42. Langhendries JP, Detry J, Van Hees J, et al. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr. 1995;21:177-181.
43. Bullen CL, Tearle PV, Stewart MG. The effect of "humanised" milks and supplemented breast feeding on the faecal flora of infants. J Med Microbiol. 1977;10:403-413.
44. Willis AT, Bullen CL, Williams K, Fagg CG, Bourne A, Vignon M. Breast milk substitute: a bacteriological study. Br Med J. 1973;4: 67-72.
45. Cummings JH. Short chain fatty acids in the human colon. Gut. 1981;22:763.
46. Midtvedt AC, Midtvedt T. Production of short chain fatty acids by the intestinal microflora during the first 2 years of human life. J Pediatr Gastroenterol Nutr. 1992;15:395-403.
47. Flickinger EA, Hatch TF, Wofford RC, Grieshop CM, Murray SM, Fahey GC Jr. In vitro fermentation properties of selected fructooligosaccharide-containing vegetables and in vivo colonic microbial populations are affected by the diets of healthy human infants. J Nutr. 2002;132:2188-2194.
48. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138:1091-1095.
49. Bruzzese E, Volpicelli M, Squeglia V, et al. A formula containing galacto-and fructo-oligosaccharides prevents intestinal and extraintestinal infections: an observational study. Clin Nutr. 2009;28:156-161.
50. Jensen RG, ed. Handbook of Milk Composition. New York: Academic Press; 1995.